vimarsana.com
Home
Live Updates
Liso-Cel Improves Outcomes in Relapsed/Refractory Large B-Ce
Liso-Cel Improves Outcomes in Relapsed/Refractory Large B-Ce
Liso-Cel Improves Outcomes in Relapsed/Refractory Large B-Cell Lymphoma
Ian Flinn, MD, leads a roundtable discussion with Loretta Nastoupil, MD, and Amitkumar Mehta, MD
Related Keywords
Tennessee ,
United States ,
Nashville ,
Texas ,
Amitkumar Mehta ,
Amit Mehta ,
Loretta Nastoupil ,
Ian Flinn ,
American Society Of Hematology ,
University Of Texas Md Anderson Cancer Center ,
Md Anderson Cancer Center ,
Sarah Cannon Research Institute In Nashville ,
University Of Alabama At Birmingham ,
Page Today ,
Sarah Cannon Research Institute ,
Cancer Center ,
Im Ian Flinn ,
Positive Study ,
What Will ,
New Standard ,
Aggressiveb Cell ,